DIAGNOS (ADK) Stock Price, News & Analysis

Company Overview

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. DIAGNOS Inc. was founded in 1998 and is headquartered in Brossard, Canada.

Key Stats

• Today's Range: C$0.26 to C$0.27
• 50-Day Range: C$0.26 to C$0.38
• 52-Week Range: C$0.23 to C$0.57
• Volume: 53,500 shs
• Average Volume: 92,164 shs
• Market Capitalization: C$20.77 million
• P/E Ratio: N/A
• Dividend Yield: 0.29%
• Price Target: C$1.50
• Consensus Rating: Strong Buy

ADK Stock Analysis - Frequently Asked Questions

How have ADK shares performed this year?

DIAGNOS's stock was trading at C$0.41 on January 1st, 2024. Since then, ADK shares have decreased by 37.0% and is now trading at C$0.26.
View the best growth stocks for 2024 here.

How do I buy shares of DIAGNOS?

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some other companies that DIAGNOS investors own include DIAGNOS (DGNOF), Facedrive (FDVRF), New Found Gold (NFGC), Ackroo (AKR), BeWhere (BEW), BlueRush (BTV) and Grande West Transportation Group (BUS).

Company Calendar

• Today: 11/21/2024
• Next Earnings (Estimated): 11/26/2024

Industry, Sector and Symbol

• Stock Exchange: CVE
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: N/A
• Current Symbol: CVE:ADK
• CUSIP: N/A
• CIK: N/A
• Web: www.diagnos.ca
• Phone: +1-450-6788882
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: C$1.50
• High Stock Price Target: C$1.50
• Low Stock Price Target: C$1.50
• Potential Upside/Downside: +488.2%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): C($0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: C$-3,090,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: -134.33%

Debt

• Debt-to-Equity Ratio: 245.28
• Current Ratio: 0.39
• Quick Ratio: 0.68

Sales & Book Value

• Annual Sales: C$577,486.00
• Price / Sales: 35.96
• Cash Flow: C$0.00 per share
• Price / Cash Flow: 60.00
• Book Value: C($0.03) per share
• Price / Book: -8.50

Miscellaneous

• Outstanding Shares: 81,440,000
• Free Float: N/A
• Market Cap: C$20.77 million
• Optionable: Not Optionable
• Beta: -0.44